IgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSGNOTTO, Fabio D. R.
dc.contributor.authorOLIVEIRA, Marilia G. de
dc.contributor.authorLIRA, Aline A. L.
dc.contributor.authorINOUE, Amanda H. S.
dc.contributor.authorTITZ, Tiago O.
dc.contributor.authorORFALI, Raquel L.
dc.contributor.authorBENTO-DE-SOUZA, Luciana
dc.contributor.authorSATO, Maria N.
dc.contributor.authorAOKI, Valeria
dc.contributor.authorDUARTE, Alberto J. S.
dc.contributor.authorVICTOR, Jefferson R.
dc.date.accessioned2018-07-05T18:02:30Z
dc.date.available2018-07-05T18:02:30Z
dc.date.issued2018
dc.description.abstractIntroductionOur group recently demonstrated that IgG modulates T cell cytokine production during the maturation process in the human thymus. The effects of this modulation are IgG repertoire dependent and can exert a systemic and long-term impact. ObjectiveTo investigate whether IgG from atopic dermatitis (AD) patients can modulate cytokine production of infant intrathymic TCD4 and TCD8 cells in vitro. MethodsThymic tissues were obtained from newborn children from nonatopic mothers, and thymocytes were cultured for 6 days with purified IgG from AD patients or with intravenous immunoglobulin (IVIG) or mock conditions as controls. Cells were gated as double positive T cells (TDP(-)CD4(+)CD8(+)), TCD4 cells (CD4(+)CD8(-)), or TCD8 cells (CD4(-)CD8(+)), and intracellular levels of IL-17A, IFN-, TNF-, IL-4, IL-10, and TGF- were evaluated by flow cytometry. ResultsCompared to mock and IVIG culture conditions, IgG of AD individuals induced in vitro intracellular production of IL-17 and IL-10 by intrathymic TDP, TCD4, and TCD8 cells of infants. TGF- was also detected at a higher frequency in response to AD IgG in TDP and TCD8 cells compared to mock and IVIG cultured conditions. An opposite effect was detected upon IFN- production in TCD4 cells, such that AD IgG reduced IFN- production compared to production under mock conditions but not under IVIG conditions. ConclusionIgG of AD patients can stimulate cytokine production in infant thymocytes and thus resembles the peripheral profile observed in adults. These findings suggest a novel mechanism that can contribute to AD pathogenesis.
dc.description.indexMEDLINE
dc.description.sponsorshipLaboratory of Medical Investigation-56, Medical School, University of Sao Paulo, Sao Paulo, Brazil [LIM-56 HC-FMUSP]
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2015/17256-3]
dc.description.sponsorshipSao Paulo Administrative Development Foundation (FUNDAP)
dc.description.sponsorshipNational Council for Scientific and Technological Development (CNPq) [115603/2015-8]
dc.identifier.citationINTERNATIONAL JOURNAL OF DERMATOLOGY, v.57, n.4, p.434-440, 2018
dc.identifier.doi10.1111/ijd.13907
dc.identifier.eissn1365-4632
dc.identifier.issn0011-9059
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/26931
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofInternational Journal of Dermatology
dc.rightsrestrictedAccess
dc.rights.holderCopyright WILEY
dc.subject.othertumor-necrosis-factor
dc.subject.otheri hypersensitivity response
dc.subject.othermaternal immunization
dc.subject.otherdermatophagoides-pteronyssinus
dc.subject.otherinterleukin-10 production
dc.subject.otherallergen exposure
dc.subject.otherskin inflammation
dc.subject.othercytokine profiles
dc.subject.otherdendritic cells
dc.subject.otheroral tolerance
dc.subject.wosDermatology
dc.titleIgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalOLIVEIRA, Marilia G. de:Univ Sao Paulo, Lab Med Invest LIM 56, Div Dermatol, Sch Med, Ave Dr Eneas Carvalho Aguiar 500,3rd Floor, BR-05403000 Sao Paulo, Brazil
hcfmusp.author.externalTITZ, Tiago O.:Univ Sao Paulo, Lab Med Invest LIM 56, Div Dermatol, Sch Med, Ave Dr Eneas Carvalho Aguiar 500,3rd Floor, BR-05403000 Sao Paulo, Brazil
hcfmusp.author.externalBENTO-DE-SOUZA, Luciana:Univ Sao Paulo, Lab Med Invest LIM 56, Div Dermatol, Sch Med, Ave Dr Eneas Carvalho Aguiar 500,3rd Floor, BR-05403000 Sao Paulo, Brazil
hcfmusp.citation.scopus21
hcfmusp.contributor.author-fmusphcFABIO DA RESSURREICAO SGNOTTO
hcfmusp.contributor.author-fmusphcALINE APARECIDA DE LIMA LIRA
hcfmusp.contributor.author-fmusphcAMANDA HARUMI SABO INOUE
hcfmusp.contributor.author-fmusphcRAQUEL LEAO ORFALI
hcfmusp.contributor.author-fmusphcMARIA NOTOMI SATO
hcfmusp.contributor.author-fmusphcVALERIA AOKI
hcfmusp.contributor.author-fmusphcALBERTO JOSE DA SILVA DUARTE
hcfmusp.contributor.author-fmusphcJEFFERSON RUSSO VICTOR
hcfmusp.description.beginpage434
hcfmusp.description.endpage440
hcfmusp.description.issue4
hcfmusp.description.volume57
hcfmusp.origemWOS
hcfmusp.origem.pubmed29355930
hcfmusp.origem.scopus2-s2.0-85043487873
hcfmusp.origem.wosWOS:000427119800012
hcfmusp.publisher.cityHOBOKEN
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceBatista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753
hcfmusp.relation.referenceBelderbos ME, 2012, CLIN EXP ALLERGY, V42, P66, DOI 10.1111/j.1365-2222.2011.03857.x
hcfmusp.relation.referenceBento-de-Souza Luciana, 2016, Results Immunol, V6, P15, DOI 10.1016/j.rinim.2016.04.001
hcfmusp.relation.referenceCzarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P941, DOI 10.1016/j.jaci.2015.05.049
hcfmusp.relation.referenceSgnotto FD, 2017, HUM VACC IMMUNOTHER, V13, P1563, DOI 10.1080/21645515.2017.1299299
hcfmusp.relation.referenceLira AAD, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-47
hcfmusp.relation.referencede Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8
hcfmusp.relation.referencede Saint-Vis B, 1998, J IMMUNOL, V160, P1666
hcfmusp.relation.referenceEsaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013
hcfmusp.relation.referenceFusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865
hcfmusp.relation.referenceFusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x
hcfmusp.relation.referenceFusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x
hcfmusp.relation.referenceFutata EA, 2006, IMMUNOBIOLOGY, V211, P157, DOI 10.1016/j.imbio.2005.08.006
hcfmusp.relation.referenceGurkan A, 2016, ACTA DERMATOVENER CR, V24, P268
hcfmusp.relation.referenceHamel Y, 2016, J AUTOIMMUN, V73, P54, DOI 10.1016/j.jaut.2016.06.003
hcfmusp.relation.referenceHan SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488
hcfmusp.relation.referenceHanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x
hcfmusp.relation.referenceHuang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016
hcfmusp.relation.referenceJARRETT EEE, 1983, IMMUNOLOGY, V48, P49
hcfmusp.relation.referenceJenmalm MC, 2000, CLIN EXP ALLERGY, V30, P34, DOI 10.1046/j.1365-2222.2000.00771.x
hcfmusp.relation.referenceKaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017
hcfmusp.relation.referenceKim HS, 2015, STEM CELLS, V33, P1254, DOI 10.1002/stem.1913
hcfmusp.relation.referenceKoga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111
hcfmusp.relation.referenceLemieux W, 2005, MOL IMMUNOL, V42, P839, DOI 10.1016/j.molimm.2004.07.046
hcfmusp.relation.referenceLesiak A, 2014, ARCH MED SCI, V10, P1239, DOI 10.5114/aoms.2014.47833
hcfmusp.relation.referenceLi J, 2015, PROCEEDINGS 3RD IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION ACPR 2015, P1, DOI 10.1109/ACPR.2015.7486454
hcfmusp.relation.referenceMa L, 2014, J EUR ACAD DERMATOL, V28, P1079, DOI 10.1111/jdv.12288
hcfmusp.relation.referenceMartel BC, 2016, INFLAMM RES, V65, P265, DOI 10.1007/s00011-015-0912-z
hcfmusp.relation.referenceMuniz BP, 2014, IMMUNOBIOLOGY, V219, P377, DOI 10.1016/j.imbio.2014.01.002
hcfmusp.relation.referenceNoda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015
hcfmusp.relation.referenceOliveira CR, 2005, J CLIN IMMUNOL, V25, P153, DOI 10.1007/s10875-005-2821-3
hcfmusp.relation.referenceRigato PO, 2009, IMMUNOTHERAPY, V1, P141, DOI [10.2217/1750743X.1.1.141, 10.2217/1750-743X.1.1.141]
hcfmusp.relation.referenceSato M. N., 2002, Clinical and Experimental Allergy, V32, P1667, DOI 10.1046/j.1365-2222.2002.01429.x
hcfmusp.relation.referenceSato MN, 2001, J INTERF CYTOK RES, V21, P827, DOI 10.1089/107999001753238079
hcfmusp.relation.referenceSeltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076
hcfmusp.relation.referenceSeneviratne SL, 2006, CLIN EXP DERMATOL, V31, P689, DOI 10.1111/j.1365-2230.2006.02172.x
hcfmusp.relation.referenceSimon D, 2007, BRIT J DERMATOL, V157, P583, DOI 10.1111/j.1365-2133.2007.08050.x
hcfmusp.relation.referenceStach SCL, 2014, AM J REPROD IMMUNOL, V72, P555, DOI 10.1111/aji.12305
hcfmusp.relation.referenceTan Q, 2017, J CUTAN MED SURG, V21, P308, DOI 10.1177/1203475417697651
hcfmusp.relation.referenceVance GHS, 2004, CLIN EXP ALLERGY, V34, P1855, DOI 10.1111/j.1365-2222.2004.02111.x
hcfmusp.relation.referenceVANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985
hcfmusp.relation.referenceVictor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11
hcfmusp.relation.referenceVictor JR, 2017, HUM VACC IMMUNOTHER, V13, P507, DOI 10.1080/21645515.2016.1244592
hcfmusp.relation.referenceVictor JR, 2014, J IMMUNOL RES, DOI 10.1155/2014/780386
hcfmusp.relation.referenceVictor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39
hcfmusp.relation.referenceVolz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291
hcfmusp.relation.referenceWANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
hcfmusp.relation.referenceWeidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X
hcfmusp.relation.referenceWitte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308
hcfmusp.relation.referenceWu KH, 2006, PEDIATR ALLERGY IMMU, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x
hcfmusp.scopus.lastupdate2024-04-18
relation.isAuthorOfPublicationd6287d4b-423d-423b-99e5-1598f808e87b
relation.isAuthorOfPublicationd386a75f-f8b0-4d10-949f-5a28128c5c76
relation.isAuthorOfPublication5e89bc64-02dc-4c83-8407-267dfb12ede3
relation.isAuthorOfPublicationdf47e77e-6254-42ee-ae92-a5d4ddbed94b
relation.isAuthorOfPublicationc5fbfe7f-eec0-49ea-be33-ce5f13cc3dfb
relation.isAuthorOfPublication39977d9c-4d58-4ad3-9df5-f4625a05e3b3
relation.isAuthorOfPublication8e4f2c15-06a5-444b-826d-84576403144e
relation.isAuthorOfPublication3f9cbc83-dc25-45f8-92f6-0f2c6f6de420
relation.isAuthorOfPublication.latestForDiscoveryd6287d4b-423d-423b-99e5-1598f808e87b
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SGNOTTO_IgG_from_atopic_dermatitis_patients_induces_IL17_and_2018.PDF
Tamanho:
227.17 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)